Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Schett
Steven L Teitelbaum

Showing results (71-80 of 1,160) with videos related to

Pageof 116
Sort By:
Nature Communications|August 17, 2018
Resolution of chronic inflammatory disease: universal and tissue-specific conceptsGeorg Schett, Markus F Neurath
Nature Clinical Practice. Rheumatology|October 8, 2008
Denosumab--a novel strategy to prevent structural joint damage in patients with RA?Georg Schett, Jean-Pierre David
Current Pharmaceutical Design|September 24, 2005
New insights in the mechanism of bone loss in arthritisGeorg Schett, Josef S Smolen
The Journal of Cell Biology|December 31, 2014
Absence of Dap12 and the αvβ3 integrin causes severe osteopetrosisWei Zou, Steven L Teitelbaum
Calcified Tissue International|April 15, 2018
OsteoimmunologyStuart H Ralston, Georg Schett
Rheumatology (Oxford, England)|March 12, 2020
Enthesitis in psoriatic arthritis (Part 1): pathophysiologyElizabeth G Araujo, Georg Schett
Nature Reviews. Rheumatology|December 1, 2020
Key opinion leaders - a critical perspectiveJose U Scher, Georg Schett
Nature Reviews. Rheumatology|September 30, 2018
Effects of the IL-23-IL-17 pathway on bone in spondyloarthritisEllen M Gravallese, Georg Schett
Bone|March 10, 2018
Congenital disorders of bone and bloodAnna Teti, Steven L Teitelbaum
Annals of the New York Academy of Sciences|April 16, 2010
Integrins, growth factors, and the osteoclast cytoskeletonWei Zou, Steven L Teitelbaum
Pageof 116

Showing results (71-80 of 1,160) with videos related to

Sort By:
Pageof 116
Nature Communications|August 17, 2018
Resolution of chronic inflammatory disease: universal and tissue-specific conceptsGeorg Schett, Markus F Neurath
Nature Clinical Practice. Rheumatology|October 8, 2008
Denosumab--a novel strategy to prevent structural joint damage in patients with RA?Georg Schett, Jean-Pierre David
Current Pharmaceutical Design|September 24, 2005
New insights in the mechanism of bone loss in arthritisGeorg Schett, Josef S Smolen
The Journal of Cell Biology|December 31, 2014
Absence of Dap12 and the αvβ3 integrin causes severe osteopetrosisWei Zou, Steven L Teitelbaum
Calcified Tissue International|April 15, 2018
OsteoimmunologyStuart H Ralston, Georg Schett
Rheumatology (Oxford, England)|March 12, 2020
Enthesitis in psoriatic arthritis (Part 1): pathophysiologyElizabeth G Araujo, Georg Schett
Nature Reviews. Rheumatology|December 1, 2020
Key opinion leaders - a critical perspectiveJose U Scher, Georg Schett
Nature Reviews. Rheumatology|September 30, 2018
Effects of the IL-23-IL-17 pathway on bone in spondyloarthritisEllen M Gravallese, Georg Schett
Bone|March 10, 2018
Congenital disorders of bone and bloodAnna Teti, Steven L Teitelbaum
Annals of the New York Academy of Sciences|April 16, 2010
Integrins, growth factors, and the osteoclast cytoskeletonWei Zou, Steven L Teitelbaum
Pageof 116